# Combination Therapy Selection Trial in Amyotrophic Lateral Sclerosis

> **NCT00355576** · PHASE2 · COMPLETED · sponsor: **Columbia University** · enrollment: 86 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** Celecoxib
- **DRUG:** Creatine
- **DRUG:** Minocycline

## Key facts

- **NCT ID:** NCT00355576
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2011-02-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00355576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00355576, "Combination Therapy Selection Trial in Amyotrophic Lateral Sclerosis". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00355576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*